Clinical trial failures

Sponsor hub

City of Hope Medical Center clinical trial failures

Review 57 stopped clinical trials from City of Hope Medical Center, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 8 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials57
Likely biological signals8
Shown below57

Dominant stop reasons

OTHER/UNKNOWN
25
OPERATIONAL
24
EFFICACY/FUTILITY
4
SAFETY
4

Notable sponsors

City of Hope Medical Center
57

Related phases

Phase I
33
Phase II
16
Unknown
4
Early Phase I
2
Phase III
2

Crawlable stopped-trial records

Open Explore

Showing up to 57 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT00540995: Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Phase I Adult Acute Myeloid Leukemia in Remission trial by City of Hope Medical Center. Stop reason: SAFETY.

Unable to safely escalate to TMLI doses that were hypothesized to be effective and less toxic than FTBI. Likely due to the giving of Busulfan prior to radiation delivery. Therefore, the study was abandoned and no further patients were accrued.